• 08:30 - 09:00
• Sponsored by: Longevity Holdings
• EY, London

Conference Registration and Welcome Coffee Break

• 09:00 - 09:05
• Conference Chair: Ben Grainger, EY
• EY, London

Welcome From Our Conference Chair

• 09:05 - 09:45
• Professor Richard Faragher, Brighton University
• EY, London

Keynote Presentation - Tackling Ageing: Hopes, Fears and Black Swans

A consensus exists within biogerontology that some of the mechanisms causing mammalian ageing are known and druggable. These mechanisms will be explained and their potential effects on longevity risk and the disruption of mortality assumptions discussed. However, alpha opportunities also now exist for investors who can integrate biogerontological expertise into their traditional actuarial models.

• 09:45 - 10:30
• Chair: Joe Tolen, Cambridge Associates | Lara Desay, Hymans Robertson | Ryan McTernan, Fifth Season Investments | David Horley, Schroders Capital
• EY, London

Panel - State of the Life ILS Market

The longevity and mortality markets are multi-faceted and each has its own idiosyncracies that affect the performance of an investment. The state of the market panel sees three industry leaders from the life settlement, life ILS and pension risk transfer markets provide a helicopter view of what topics, themes or trends are impacting their segment of the longevity and mortality markets currenty.

• 10:30 - 11:00
• Sponsored by: Wilmington Trust
• EY, London

Morning Coffee Break

• 11:00 - 11:20
• Matt Meija, Preston Capital
• EY, London

Presentation - An Investor’s Perspective on the Life Settlement Market

Life settlements provides investor portfolios with a range of benefits but many of these are either misunderstood or drowned out by perceived risks. In his presentation, Matt Mejia, Managing Director at Preston Capital, offers his perspective on the nuances of the asset class and the outlook for it through the rest of the year and beyond.

• 11:20 - 11:40
• Tom Spreutels, Leadenhall Capital Partners
• EY, London

Presentation - Life ILS: Balancing Risk Supply With Institutional Investor Demand

Over its history the Life ILS markets have featured a range of investment exposures that have attracted a corresponding range of institutional investors. In this presentation we consider the Life ILS investment opportunity set as it stands in 2025 examining both the supply of risks and institutional investor demands for these risks.

• 11:40 - 12:00
• Arik Rashkes, Solomon Partners
• EY, London

Presentation - The Life Insurance Market (R)evolution, Where Alternative Investments Become Conventional

The life insurance industry has undergone significant transformation, particularly in the years following the global financial crisis. The entry of private equity firms and other alternative asset managers has been a key driver of this evolution, reshaping traditional models and investment strategies. This presentation will explore the factors behind this shift, examine its impact on the industry, and consider the potential trajectory of the life insurance market in the years ahead.

• 12:00 - 12:20
• Chair: Greg Winterton, Life Risk News | Arik Rashkes, Solomon Partners
• EY, London

Supply and Demand Dynamics Q&A Session

Following the three presentations relating to demand and supply dynamics in the life insurance-related markets, Life Risk News’ Greg Winterton hosts a Q&A session where the audience will be able to pose questions to the presenters.

• 12:20 - 13:20
• Sponsored by: BroadRiver Asset Management
• EY, London

Lunch Break

• 13:20 - 14:00
• Chair: Kirsty Maclean, Willkie Farr & Gallagher | David Griffiths, Willkie Farr & Gallagher | Michael Millette, Hudson Structured Capital Management
• EY, London

Panel - The Outlook for Growth in the Life (Re)insurance Sidecar Market

Reinsurance and sidecar structures are gaining momentum in the life insurance industry, offering capital efficiency and access to alternative risk transfer. This panel will examine the drivers behind recent growth, the outlook for continued expansion, and the evolving role of sidecars in life risk financing. Panellists will also explore what investors need to know about structuring, risk-return dynamics, and considerations for entering this specialised but growing market.

• 14:00 - 14:50
• Chair: George Belcher, Mayer Brown | Ben Grainger, EY | Luca Tres, Guy Carpenter | Benjamin Kieffer, Goldman Sachs
• EY, London

Panel - Innovation in Longevity Risk

The (re)insurance markets are well-used to trading longevity risk. Life and longevity sidecars are now an established concept. What are the new opportunities for other non-traditional participations in longevity risk, and associated assets? How does this link with the world of securitisation, asset-based capital charges and other regulatory considerations/ associated issues in the principal jurisdictions of the UK, Bermuda and the US? This panel discusses both recent and future developments that look set to drive further activity in this market.

• 14:50 - 15:30
• Sponsored by: Actuarial Risk Management
• EY, London

Afternoon Coffee Break

• 15:30 - 15:50
• Dan Poole, Club Vita
• EY, London

Presentation - Mortality Modelling for Longevity Markets

This session will first explore the techniques typically used by insurers and reinsurers to model longevity in the pension risk transfer market, with a focus on allowance for socioeconomic factors. It will then go on to consider how that approach may be applicable to the other longevity/mortality markets.

• 15:50 - 16:10
• Corwin Zass, Actuarial Risk Management (ARM)
• EY, London

Presentation - The ‘Healthy Wealthy’ Population of the Life Settlement Market

Discover how wealth and longevity are powerfully linked in the life settlement market. This presentation reveals key mortality trends, underwriting considerations, and actionable insights to improve pricing, manage tail risk, and optimize portfolios in today’s investor landscape.

• 16:10 - 16:30
• Matthew Sheridan, Health Data Analytics Institute (HDAI)
• EY, London

Presentation - Drivers of Socio-Economic Variation in Mortality Modelling

The healthcare industry is paying increasing attention to social determinants of health (“SDOH”). This talk will reveal some of the ways HealthTech company, HDAI, is extracting and using this information in predictive modelling, and how these insights translate to the market for longevity risk.

• 16:30 - 17:00
• Chair: Stuart McDonald, Lane Clark & Peacock | Corwin Zass, ARM | Matthew Sheridan, HDAI | Dan Poole, Club Vita
• EY, London

Panel - Understanding Mortality Q&A Session

Folliowing the three presentations relating to mortality modelling in the life risk space, LCP’s Stuart MacDonald hosts a Q&A session where the audience will be able to pose questions to both him and the presenters.

• 17.00 - 19:00
• Sponsored by: Corry Capital Advisors
• Sky Bar, London

Cocktail Reception